Abbott wins approval for hemoglobin test in Europe

05/13/2013 | RTT News

Abbott Laboratories has obtained CE mark approval to market its ARCHITECT clinical chemistry Hemoglobin A1c test in Europe. The blood assay, which measures an individual's average blood glucose level over the most recent three months, is intended to help doctors diagnose and monitor patients with diabetes, as well as identify those who may be at risk for developing the illness.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ